Free Shipping Over $250

SUFU 2007 - Urinary Frequency and Urge Urinary Incontinence in BOTOX®™ Repeated Injections: Outcome Data Using Voiding Diaries and UDI-6 Correlation

Intradetrusor Botulinum toxin type A (BTX-A) injection has emerged as a novel therapeutic option for the treatment of idiopathic overactive bladder (I-OAB) refractory to oral antimuscarinic agents. We designed an IRB approved prospective trial to evaluate the improvement in urinary frequency (UF) and urge urinary incontinence (UUI) using voiding diaries (VD), urodynamic findings, validated symptomatic improvement, and quality of life in I-OAB patients submitted to a scheduled re-injection BTX-A protocol. For the Full Story:®_repeated_injections_outcome_data_using_voiding_diaries_and_udi6_correlation.html
Back to all posts
Contact Support
  • Phone1-866-892-2032
  • Mon-Fri9am to midnight EST
  • Sat-Sun10am to 5pm EST
  • WhatsApp
  • Viber
  • WeChat
  • Facebook Messenger